Video

Clinical Leader Live: In-House Vs. Outsource: Considerations For Biotechs

Source: Clinical Leader

Laurie Halloran, President & CEO, Halloran Consulting, joined Clinical Leader for an interactive presentation and Q&A session exploring what every small to mid-sized pharma and biotech company should consider when evaluating their outsourcing plan. During this call, Laurie discussed:

  • If your outsourcing strategy isn’t working, what should you do?
  • How are you building your internal capabilities to enable programs that facilitate longer term program support?
  • What new approaches are you engaging to enable data-driven innovation to play a role in supporting more efficient drug development?
  • Is your current outsourcing operating model too rigid to experiment with the cutting-edge technology when its efficiency drives margins down for the CROs?

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: